FTC sues key pharmacy reward managers over insulin costs The company brought action in opposition to Caremark, Categorical Scripts and Optum Rx, arguing their “anticompetitive and unfair” rebating practices “artificially inflated” the list price of everyday living-conserving insulin medications. The offer have to be done by Sept. 30 or buyers https://cruztwbfh.answerblogs.com/30829080/facts-about-healthcare-news-revealed